Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Immunogenicity and Safety Study of a Vaccine Against Lyme Borreliosis, in Healthy Adults Aged 18 to 65 Years. Randomized, Controlled, Observer-blind Phase 2 Study.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03769194
Recruitment Status : Recruiting
First Posted : December 7, 2018
Last Update Posted : December 18, 2018
Sponsor:
Information provided by (Responsible Party):
Valneva Austria GmbH

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : January 2020
  Estimated Study Completion Date : October 2020